bromodeoxyuridine has been researched along with Brain Neoplasms in 191 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 80 (41.88) | 18.7374 |
| 1990's | 77 (40.31) | 18.2507 |
| 2000's | 19 (9.95) | 29.6817 |
| 2010's | 15 (7.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biltekin, B; Çetin, A; Degirmencioglu, S | 1 |
| Cao, L; Chen, J; Hu, J; Lin, J; Lin, S; Mao, L; Ouyang, Y; Yan, G; Yang, X; Zhang, H; Zhou, Y; Zhu, W | 1 |
| Cairncross, G; Döring, A; Dunn, JF; Forsyth, P; Hader, W; Hamilton, M; Kelly, J; Kinniburgh, D; Lun, X; Mercier, P; Robbins, S; Sarkar, S; Silva, C; van Rooijen, N; Wang, X; Weiss, S; Yong, VW; Zemp, FJ | 1 |
| Chen, G; Jia, B; Tan, WQ; Ye, M | 1 |
| Bannykh, S; Danielpour, M; Gate, D; Town, T | 1 |
| Hamaoka, Y; Katoh, H; Negishi, M | 1 |
| Heth, J; Hoff, JT; Hua, Y; Keep, RF; Muraszko, KM; Tang, L; Xi, G | 1 |
| Heneka, MT; Hermes, M; Kummer, MP; Orlandi, M; Papi, A; Tatenhorst, L; Terwel, D | 1 |
| Cho, KG; Kim, JH; Kim, SU; Lee, JE | 1 |
| Chen, YY; Li, BA; Liu, XY; Shen, SH; Tan, GW; Wang, HD; Wang, ZX; Zhu, HW | 1 |
| Bieńkowski, M; Grešner, SM; Hułas-Bigoszewska, K; Ironside, JW; Jaskólski, DJ; Kolasa, M; Kulczycka-Wojdala, D; Liberski, PP; Papierz, W; Piaskowski, S; Rieske, P; Stawski, R; Stoczyńska-Fidelus, E; Witusik-Perkowska, M; Zakrzewska, M; Zakrzewski, K | 1 |
| Hu, JG; Li, XW; Lü, HZ; Wang, FC; Wang, XF; Zhou, JS | 1 |
| Jia, Q; Jiang, W; Liu, L; Ma, N; Tan, A; Zhang, H; Zhao, X | 1 |
| Bugyik, E; Dezso, K; Döme, B; Klepetko, W; László, V; Nagy, P; Paku, S; Reiniger, L; Tímár, J; Tóvári, J | 1 |
| Agarwal, A; Bittner, P; Dahiya, S; Joshi, N; Leonard, JR; Piwnica-Worms, D; Smith, E; Taylor, S; Weber, J; Xu, Z | 1 |
| Cordes, N; Eke, I; Faethe, C; Kästner, I; Mueller-Klieser, W; Schackert, G; Storch, K; Taucher-Scholz, G; Temme, A; Vehlow, A | 1 |
| Chan, AK; Lau, KM; Li, KK; Mao, Y; Ng, HK; Pang, JC; Poon, WS; Shi, Z; Wang, Y; Yang, L; Zhou, L | 1 |
| Binderup, L; Gumireddy, K; Ikegaki, N; Phillips, PC; Reddy, CD; Reddy, GS; Sutton, LN | 1 |
| Bronner-Fraser, M; Geschwind, DH; Hemmati, HD; Kornblum, HI; Lazareff, JA; Masterman-Smith, M; Nakano, I | 1 |
| Gorin, F; Harley, W; Jue, T; Lyeth, B; Schnier, J | 1 |
| Lehnert, S; Li, Y; Owusu, A | 1 |
| Buckner, JC; Cascino, TL; Curran, WJ; Davis, R; Greenberg, HS; Gutin, P; Phillips, T; Prados, MD; Sandler, HM; Schultz, C; Seiferheld, W; Urtasun, R | 1 |
| Archer, DR; Ciliax, B; Davis, T; Glass, JD; Hau, V; Joshi, HC; Landen, JW; Van Meir, EG; Wainer, BH; Wang, M | 1 |
| McDermott, MW; Quiñones-Hinojosa, A; Sanai, N; Smith, JS | 1 |
| Beck, M; Feinstein, DL; Grommes, C; Heneka, MT; Jacobs, AH; Landreth, GE; Sastre, M; Schlegel, U | 1 |
| Adamczyk, A; Gasinska, A; Glinski, B; Krzyszkowski, T; Niemiec, J; Skolyszewski, J; Zabek, M | 1 |
| Alberta, JA; Anderson, DJ; Bachoo, RM; Depinho, RA; Huillard, E; Kane, M; Kesari, S; Ligon, KL; Liu, H; Louis, DN; Mehta, S; Rowitch, DH; Stiles, CD | 1 |
| Bengzon, J; Bexell, D; Gunnarsson, S; Nordquist, J | 1 |
| Götz, J; Hoerndli, FJ; Papassotiropoulos, A; Pelech, S | 1 |
| Barone, TA; DeChant, A; Hoffer, A; Lock, J; Mangla, S; Miller, RH; Morrow, J; Plunkett, RJ; Selkirk, SM | 1 |
| Hoshino, T; Nagai, M; Sano, K; Sato, F; Tsuchida, T | 1 |
| Sano, K | 4 |
| Glatstein, E; Kinsella, TJ; Kornblith, PL; McPherson, S; Mitchell, JB; Rowland, J; Russo, A; Smith, BH | 1 |
| Kohno, T; Shitara, N; Takakura, K | 1 |
| Hugues, P; Montaudon, D; Robert, J | 1 |
| Collins, JM; Jenkins, J; Kinsella, TJ; Kornblith, P; Mitchell, JB; Myers, CE; Rowland, J; Russo, A; Schwade, J; Speyer, J | 1 |
| Glatstein, E; Kinsella, TJ; Mitchell, JB; Morstyn, G; Russo, A | 1 |
| Hoshino, T; Nagashima, T | 3 |
| Gutin, PH; Wilson, CB | 1 |
| Levin, EM; Levin, VA; Phuphanich, S | 1 |
| Bodell, WJ; Rasmussen, J | 1 |
| Collins, J; Gianni, L; Glatstein, E; Jenkins, J; Kinsella, TJ; Klecker, RW; Mitchell, JB; Myers, C; Rowland, J; Russo, A | 1 |
| Handa, J; Matsumura, K; Nakajima, M; Nakasu, S; Nioka, H | 1 |
| Davis, RL; Hoshino, T; Onda, K; Shibuya, M; Wilson, CB | 1 |
| Brown, SL; Freytag, SO; Kim, JH; Kim, OB; Kim, SH; Kolozsvary, A | 1 |
| Kurihara, H; Matsuzaki, S; Sugimoto, H; Tamura, M; Tsukahara, T; Yamazaki, H | 1 |
| Leibel, SA; Phillips, TL; Rotman, M; Scott, CB; Weigensberg, IJ | 1 |
| Dhir, R; Dinda, AK; Karak, AK; Kharbanda, K; Mathur, M; Roy, S; Sarkar, C | 1 |
| Davis, RL; Gutin, PH; Lamborn, K; Levin, VA; Phillips, TL; Prados, MR; Wara, WM; Wilson, CB | 1 |
| Freese, A; Judy, K; O'Connor, MJ; O'Rourke, D | 1 |
| Chandler, KL; Davis, RL; Hoshino, T; Ito, S; Lamborn, K; Malec, MK; Prados, MD; Wilson, CB; Wynne, J | 1 |
| Izumi, I; Kowada, M; Mineura, K; Watanabe, K | 2 |
| Kurihara, H; Ono, N; Tamura, M; Zama, A | 1 |
| Bromberg, J; Chandler, WF; Crane, D; Ensminger, WD; Greenberg, HS; Junck, L; McKeever, P; Page, MA; Sandler, H; Tankanow, R | 1 |
| Ahn, DK; Davis, RL; Hoshino, T; Prados, MD; Wacker, MR | 1 |
| Bruner, JM; Hess, KR; Levin, VA; Ritter, AM; Sawaya, R | 1 |
| Davis, RL; Hoshino, T; Onda, K; Wilson, CB | 1 |
| Ito, H; Nagatsugu, Y; Nishizaki, T; Ohshita, N; Orita, T; Sasaki, K | 1 |
| Aoyagi, M; Hirakawa, K; Nagano, N; Sasaki, H | 1 |
| Steinberg, JJ | 1 |
| Ahn, D; Hoshino, T; Lamborn, K; Prados, MD; Wilson, CB | 1 |
| Davis, RL; Hoshino, T; Ito, S; Shibuya, M | 1 |
| Dinda, AK; Karak, AK; Kharbanda, K; Mathur, M; Roy, S; Sarkar, C | 1 |
| Atkinson, EN; Bruner, JM; Connelly, JH; Mourad, WA; Sembera, DL | 1 |
| Davis, RL; Hoshino, T; Ito, S; Shibuya, M; Wilson, CB | 1 |
| Davis, RL; Hoshino, T; Lamborn, K; Onda, K; Shubuya, M | 1 |
| Ishihara, H; Ito, H; Mimura, Y; Murakami, T; Nishizaki, T; Ohshita, N | 1 |
| Barker, FG; Chang, SM; Davis, RL; Gutin, PH; Lamborn, KR; Larson, DA; McDermott, MW; Prados, MD; Sneed, PK; Wilson, CB | 1 |
| Diksic, M; Takeda, N; Yamamoto, YL | 1 |
| Asai, A; Fujimaki, T; Kirino, T; Kitanaka, C; Matsuno, A; Matsutani, M; Matsuura, R; Ogai, M; Sasaki, T; Toyoda, T | 1 |
| Brunberg, JA; Greenberg, HS; Junck, L; McKeever, PE; Ross, DA; Strawderman, MS | 1 |
| Battermann, JJ; Jansen, GH; Rutgers, DH; Struikmans, H; Tulleken, CA; van der Tweel, I | 1 |
| Brenner, JW; Gokden, M; Lorenz, RG; Roth, KA; Selznick, LA | 1 |
| Asbell, S; Comis, R; Curran, W; Davis, RL; Lamborn, K; Levin, VA; Murray, K; Nelson, J; Phillips, TL; Prados, MD; Rotman, M; Rubin, P; Sause, W; Scott, CB | 1 |
| Inubushi, T; Morikawa, S; Nakajima, M; Nakasu, S | 1 |
| Davis, RL; Kaplan, SB; Lamborn, KR; Prados, MD | 1 |
| Karak, AK; Mehta, VS; Sarkar, C; Schmitt, HP; Sharma, S; Singh, R | 1 |
| Bruner, JM; Groves, MD; Hess, K; Jaeckle, KA; Kyritsis, AP; Levin, VA; Maor, MH; Meyers, C; Peterson, P; Sawaya, RE; Yung, WK | 1 |
| Battermann, JJ; Dullens, HF; Jansen, GH; Oosten, L; Rutgers, DH; Struikmans, H; Tulleken, CA; van der Tweel, I | 1 |
| Yung, WK | 1 |
| Buckner, JC; Cascino, TL; Curran, WJ; Davis, R; Greenberg, HS; Gutin, P; Phillips, T; Prados, MD; Sandler, H; Schultz, C; Scott, C; Urtasun, R | 1 |
| Kalia, VK | 1 |
| Bergström, M; Fasth, KJ; Gudjonssona, O; Kristjansson, S; Långström, B; Nyberg, G; Wu, F | 1 |
| Adamczyk, A; Gasińska, A; Krzyszk wski, T; Niemiec, J; Skołyszewski, J | 1 |
| Asai, A; Hamada, H; Kirino, T; Sakurai, S; Shibasaki, F; Shinoura, N | 1 |
| Cantz, M; Jeney, F; Kalka, D; Oravecz, K; Zs-Nagy, I | 1 |
| Mundinger, F; Ostertag, C | 1 |
| Cook, JA; Epstein, AH; Glatstein, E; Goffman, T | 1 |
| Cogen, PH; Davis, RL; Edwards, MS; Hoshino, T; Krouwer, HG; Prados, MD | 1 |
| Isoe, S; Kawaoi, A; Kimura, R; Naganuma, H; Nakano, S; Nukui, H; Sasaki, A; Suzuki, K | 1 |
| Lee, KS; Yang, WI | 1 |
| Asai, A; Davis, RL; Edwards, MS; Hoshino, T | 1 |
| Davis, RL; Edwards, MS; Hoshino, T; Ito, S; Prados, MD; Shibuya, M | 1 |
| Hoshino, T | 5 |
| Hoshino, T; Maeda, T | 1 |
| Bogdahn, U; Hoehn, H; Otto, F; Poot, M | 1 |
| Asai, A; Hoshino, T; Ito, S; Krouwer, HG; McDermott, MW; Prados, MD | 1 |
| Batorski, L; Daumas-Duport, C; Hoshino, T; Labrousse, F | 1 |
| Ahn, DK; Davis, RL; Flam, MS; Gutin, PH; Levin, VA; Phillips, TL; Prados, MD; Wara, WM; Wilson, CB | 1 |
| Kinsella, TJ; Rodriguez, R | 1 |
| Akimura, T; Furutani, Y; Ikeda, N; Ikeyama, Y; Kajiwara, K; Kamiryo, T; Nakayama, H; Nishizaki, T; Ohshita, N; Orita, T | 1 |
| Brem, SS; Brien, SE; Elkouby, MP; Gately, S; Tsanaclis, AM; Zagzag, D | 1 |
| Nose, T; Owada, T; Shirai, S; Takano, S; Yoshii, Y | 1 |
| Asai, A; Davis, RL; Dodson, BA; Hoshino, T; Ito, S; Prados, MD; Shibuya, M; Wilson, CB | 1 |
| Endo, K; Hirano, T; Igarashi, H; Inoue, T; Oriuchi, N; Shibazaki, T; Tamura, M; Tateno, M; Tomiyoshi, K; Watanabe, N | 1 |
| Detta, A; Hitchcock, E | 2 |
| Berens, ME; Jung, HW; Krouwer, HG; Rosenblum, ML | 1 |
| Furuta, T; Kunishio, K; Matsuhisa, T; Matsumi, N; Matsumoto, K; Mishima, N; Nishimoto, A; Satoh, T; Shiraishi, T; Tsuno, K | 1 |
| Ikuta, F; Ito, Y; Ozawa, T; Saito, A; Sugiyama, Y; Takahashi, H; Takeda, N; Terabayashi, T | 1 |
| Aritake, K; Asai, A; Fujimaki, T; Fukushima, T; Funada, N; Houjo, S; Koike, M; Matsutani, M; Nakamura, O; Segawa, H | 1 |
| Hyams, DM; Lampkin, BC; Mazewski, CM; Miller, MA; Raza, A; Sheikh, Y; White, LM; Yanik, GA; Yousuf, N | 1 |
| Berger, T; Crone, K; Gray, J; Lampkin, B; Mazewski, C; Miller, MA; Raza, A; Reising, J; Sawaya, R; Sheikh, Y | 1 |
| Budka, H; Kitz, K; Morimura, T; Stein, H | 1 |
| Boyd, JC; Herman, MM; Ibayashi, N; Rubinstein, LJ | 1 |
| Chandler, WF; Diaz, RF; Ensminger, WD; Gebarski, SS; Hegarty, TJ; Hood, TW; Junck, L; Page, MA; Stetson, PL; Thornton, AF | 1 |
| Averill, D; Greenberg, HS; Hegarty, TJ; Junck, L; Kincaid, MC; Page, M; Vander, JF | 1 |
| Ito, H; Kajiwara, K; Kamiryo, T; Nishizaki, T; Oshita, N | 1 |
| Butti, G; Cuomo, A; Danova, M; Gaetani, P; Giordano, M; Girino, M; Riccardi, A | 1 |
| Barcellos-Hoff, MH; Deen, DF; Marton, LJ | 1 |
| Asai, A; Barker, M; Gray, JW; Hoshino, T; Shibui, S; Vanderlaan, M | 1 |
| Assietti, R; Butti, G; Danova, M; Gaetani, P; Magrassi, L; Riccardi, A | 1 |
| Matsuoka, K; Nakamura, O; Nomura, K; Shibui, S; Takakura, K; Watanabe, T | 1 |
| Higuchi, O; Hoshino, T; Komatsu, Y; Maki, Y; Matsuki, T; Sugimoto, K; Takeuchi, S; Tsurushima, H; Yamada, Y; Yoshii, Y | 1 |
| Hirakawa, K; Houri, T; Ibayashi, N; Nakamura, K; Suzuki, K | 1 |
| Fukui, M; Inoue, T; Iwaki, T; Takeshita, I | 1 |
| Brem, S; Brien, SE; Zagzag, D | 1 |
| Kasahara, E; Miyagami, M; Tazoe, M; Tsubokawa, T | 1 |
| Aoki, H; Furutani, Y; Ikeyama, Y; Nishizaki, T; Orita, T; Sasaki, K | 1 |
| Cho, KG; Davis, RL; Hoshino, T; Lee, KS; Prados, M; Wilson, CB | 1 |
| Cho, KG; Davis, RL; Donegan, J; Hoshino, T; Nagashima, T; Slusarz, M; Wilson, CB | 1 |
| Ellis, CN; Greenberg, HS; Hegarty, TJ; McCuaig, CC; Page, MA | 1 |
| Kunimine, H; Niibe, H; Tamaki, Y; Tamura, M; Tsukahara, T; Zama, A | 1 |
| Hayashi, M; Ishii, H; Ishii, Y; Kawano, H; Nakatsugawa, S; Satoh, K | 1 |
| Nagashima, T; Takakura, K | 1 |
| Cho, KG; Hoshino, T; Lee, KS; Mampalam, TJ; Nagashima, T; Pitts, LH | 1 |
| Cho, KG; Davis, RL; Germano, IM; Hoshino, T; Ito, M; Wilson, CB | 1 |
| Budka, H; Kitz, K; Morimura, T | 2 |
| Deen, DF; Edwards, MS; Raffel, C | 2 |
| Butti, G; Cebrelli, T; Danova, M; Dionigi, P; Gaetani, P; Mazzini, G; Riccardi, A; Wilson, G | 1 |
| Ijichi, A; Kokunai, T; Kudo, H; Matsumoto, S; Okuda, Y; Saya, H; Tamaki, N; Taomoto, K | 1 |
| Collins, J; Glatstein, E; Jackson, D; Katz, D; Kinsella, T; Kornblith, P; Main, D; Rowland, J; Wright, D | 1 |
| Hayakawa, T; Mogami, H; Yoshimine, T | 1 |
| Barnwell, S; Cho, KG; De Armond, SJ; Edwards, MS; Hoshino, T | 1 |
| DeArmond, SJ; Hoshino, T; Murovic, J; Nagashima, T | 1 |
| Hoshino, T; Levin, EM; Levin, VA; Murovic, J; Nagashima, T; Rupp, SM | 1 |
| Breathnach, SM; Fine, JD | 1 |
| Davis, RL; Edwards, MS; Hoshino, T; Murovic, JA; Nagashima, T | 1 |
| Cho, KG; Hoshino, T; Nagashima, T | 1 |
| Chandler, WF; Diaz, RF; Ensminger, WD; Gebarski, SS; Greenberg, HS; Hood, TW; Junck, L; McKeever, P; Page, MA; Stetson, PL | 1 |
| Gutin, PH; Nelson, DF; Saunders, WM; Sheline, GE; Urtasun, RC | 1 |
| Brugnatelli, S; Butti, G; Buttini, R; Danova, M; Gaetani, P; Mazzini, G; Paoletti, P; Riccardi, A; Ucci, G; Wilson, GD | 1 |
| Cho, KG; Davis, RL; Edwards, MS; Hoshino, T; Lee, KS; Levin, VA; Rodriguez, LA; Wilson, CB | 1 |
| Arita, N; Hayakawa, T; Izumoto, S; Mogami, H; Nagatani, M; Oku, Y; Tzuu-Yuan, H; Ushio, Y; Yoshimine, T | 1 |
| Averill, DR; Chandler, WF; Diaz, RF; Ensminger, WD; Gebarski, SS; Greenberg, HS; Lichter, AS | 1 |
| Cho, KG; Hoshino, T; Nagashima, T; Nomura, K; Senegor, M; Waldman, F | 1 |
| Hayashi, Y; Hoshino, T; Koike, M; Matsutani, M | 1 |
| Cho, KG; Davis, RL; Edwards, MS; Hoshino, T; Hudgins, RJ; Nagashima, T | 1 |
| Broccoli, D; Vig, BK | 1 |
| Cho, KG; Hoshino, T; Nomura, K; Pitts, LH; Shimosato, Y | 1 |
| Aoki, H; Furutani, Y; Nishizaki, T; Orita, T; Saiki, M | 1 |
| Lawrence, HJ; Oster, SE | 1 |
| Barnwell, S; Cho, KG; Hoshino, T; Nagashima, T | 1 |
| Cho, KG; Edwards, MS; Hodes, JE; Hoshino, T; Murovic, JA; Nagashima, T; Pitts, LH; Wilson, CB | 1 |
| Hayakawa, T; Maruno, M; Mogami, H; Takemoto, O; Ushio, Y; Yoshimine, T | 1 |
| Kaji, K; Morimura, T | 1 |
| Davis, RL; DeArmond, SJ; Edwards, MS; Gutin, PH; Hoshino, T; Murovic, JA; Nagashima, T; Wilson, CB | 1 |
| Franke, HD | 1 |
| Hoshino, T; Nagai, M; Sano, K; Sato, F | 1 |
| Hoshino, T; Nagai, M; Sano, K | 1 |
| Lokshina, AM; Pelevina, II | 1 |
| Hoshino, T; Wilson, CB | 1 |
| Landolt, AM | 1 |
| Koyama, Y; Matsutani, M; Sing, OK; Takakura, K | 1 |
| Mundinger, F | 1 |
| Hatanaka, H | 1 |
| Fischer, HU; Jobski, C; Mundinger, F; Ostertag, C; Vogt, P | 1 |
| Takakura, K | 1 |
| Ishimori, S; Kagawa, M; Kanno, T; Moriyama, M; To, T | 1 |
14 review(s) available for bromodeoxyuridine and Brain Neoplasms
| Article | Year |
|---|---|
Techniques to assess the proliferative potential of brain tumors.
Topics: Animals; Antibodies, Antinuclear; Antibodies, Monoclonal; Antigens, Nuclear; Biological Assay; Biomarkers, Tumor; Brain Neoplasms; Bromodeoxyuridine; Cell Proliferation; Flow Cytometry; Humans; Ki-67 Antigen; Nuclear Proteins; Prognosis; Proliferating Cell Nuclear Antigen; Sensitivity and Specificity | 2005 |
Integrative treatment of gliomas.
Topics: Adjuvants, Immunologic; Adult; Boron; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Combined Modality Therapy; Female; Glioma; Humans; Interferons; Isotopes | 1983 |
[A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
Topics: Animals; Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Separation; DNA; Flow Cytometry; Glioma; Humans; Rats | 1984 |
The application of 5-bromodeoxyuridine in the management of CNS tumors.
Topics: Brain Neoplasms; Bromodeoxyuridine; Glioma; Humans; Meningeal Neoplasms; Meningioma | 1994 |
Cell kinetics of glial tumors.
Topics: Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Glioma; Humans; Kinetics; Neoplasm Invasiveness | 1992 |
Central nervous system metastasis from gallbladder carcinoma--case report.
Topics: Adenocarcinoma; Aged; Brain Neoplasms; Bromodeoxyuridine; Cisplatin; Combined Modality Therapy; Dexamethasone; Female; Frontal Lobe; Gallbladder Neoplasms; Humans; Incidence; Survival Rate | 1991 |
[Malignancy of brain tumors].
Topics: Aged; Aneuploidy; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Female; Flow Cytometry; Humans; Male; Middle Aged; Nucleolus Organizer Region | 1990 |
[Chemical modifiers in radiotherapy].
Topics: Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Glioma; Humans; Immunologic Factors; Interferon Type I; Nimustine; Radiation-Sensitizing Agents | 1989 |
Recent and current investigations of radiation therapy of malignant gliomas.
Topics: Brachytherapy; Brain; Brain Neoplasms; Bromodeoxyuridine; Carmustine; Glioma; Helium; Humans; Hyperbaric Oxygenation; Hyperthermia, Induced; Mesons; Metronidazole; Middle Aged; Misonidazole; Neon; Neutrons; Radiation-Sensitizing Agents; Radiotherapy; Radiotherapy, High-Energy | 1986 |
Proliferative potential of pediatric brain tumors.
Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; Female; Glioma; Humans; Male; Meningioma; Teratoma | 1987 |
[Radiation sensitization of brain neoplasms by haloid analogs of pyrimidine bases].
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Carcinoma, Ehrlich Tumor; Cricetinae; DNA, Neoplasm; Female; Floxuridine; Humans; Idoxuridine; Mammary Neoplasms, Experimental; Mice; Mitosis; Neoplasm Transplantation; Neoplasms, Experimental; Protein Biosynthesis; Radiation-Sensitizing Agents; Thymidine; Transcription, Genetic | 1973 |
[Significance of the combined use of radiosensitizing agents on radiotherapy of malignant encephaloma].
Topics: Brain Neoplasms; Bromodeoxyuridine; Glioblastoma; Humans; Radiation-Sensitizing Agents | 1968 |
[Management of glioma].
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cats; Glioma; Humans; Mice | 1969 |
[Current information on the treatment in neurosurgery].
Topics: Adolescent; Adult; Boron; Brain; Brain Diseases; Brain Neoplasms; Bromodeoxyuridine; Female; Humans; Male; Microsurgery; Neutrons; Radiation-Sensitizing Agents; Stereotaxic Techniques | 1971 |
16 trial(s) available for bromodeoxyuridine and Brain Neoplasms
| Article | Year |
|---|---|
Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Chemotherapy, Adjuvant; Female; Humans; Lomustine; Male; Middle Aged; Procarbazine; Radiation-Sensitizing Agents; Vincristine | 2004 |
Age and bromodeoxyuridine labelling index as prognostic factors in high-grade gliomas treated with surgery and radiotherapy.
Topics: Adult; Age Factors; Aged; Brain Neoplasms; Bromodeoxyuridine; Cell Proliferation; Combined Modality Therapy; Disease Progression; DNA, Neoplasm; Female; Flow Cytometry; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Oxygen; Ploidies; Prognosis; Sensitivity and Specificity; Staining and Labeling; Survival Rate; Treatment Outcome; Tumor Cells, Cultured | 2006 |
The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status, and future prospects: non-hypoxic cell sensitizers.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Survival; Clinical Trials as Topic; Combined Modality Therapy; Cricetinae; DNA Repair; Head and Neck Neoplasms; Humans; Idoxuridine; Mice; Neoplasms; Radiation-Sensitizing Agents | 1984 |
Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Female; Humans; Karnofsky Performance Status; Male; Middle Aged; Radiotherapy Dosage; Survival Analysis | 1995 |
A correlative study of in vivo and in vitro labeling index using bromodeoxyuridine in human brain tumors.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; Female; Humans; Hyperbaric Oxygenation; Immunohistochemistry; Infant; Male; Middle Aged | 1995 |
Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Disease-Free Survival; Glioblastoma; Humans; Lomustine; Middle Aged; Procarbazine; Vincristine | 1995 |
Radiosensitization with carotid intra-arterial bromodeoxyuridine +/- 5-fluorouracil biomodulation for malignant gliomas.
Topics: Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Fluorouracil; Glioma; Humans; Infusions, Intra-Arterial; Middle Aged; Radiation-Sensitizing Agents | 1994 |
Bromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age, and survival.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antimetabolites; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Female; Glioblastoma; Humans; Male; Middle Aged; Sex Factors; Survival Analysis | 1996 |
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Bromodeoxyuridine; Cognition; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Radiation-Sensitizing Agents; Reoperation; Vincristine | 1999 |
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Chemotherapy, Adjuvant; Disease Progression; Female; Humans; Lomustine; Male; Middle Aged; Procarbazine; Proportional Hazards Models; Radiation-Sensitizing Agents; Survival Analysis; Vincristine | 1999 |
Tumour radiosensitization with the halogenated pyrimidines 5'-bromo- and 5'-iododeoxyuridine.
Topics: Brain Neoplasms; Bromodeoxyuridine; Glioma; Head and Neck Neoplasms; Humans; Idoxuridine; Radiation-Sensitizing Agents; Sarcoma | 1992 |
Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Drug Evaluation; Female; Glioblastoma; Humans; Infusions, Intravenous; Lomustine; Male; Middle Aged; Procarbazine; Radiation-Sensitizing Agents; Survival Analysis; Vincristine | 1991 |
Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Clinical Trials as Topic; Combined Modality Therapy; Female; Glioblastoma; Humans; Infusion Pumps; Infusions, Intra-Arterial; Male; Middle Aged; Radiation-Sensitizing Agents; Survival Analysis; United States | 1990 |
The ocular effects of intracarotid bromodeoxyuridine and radiation therapy in the treatment of malignant glioma.
Topics: Adult; Animals; Brain Neoplasms; Bromodeoxyuridine; Clinical Trials as Topic; Combined Modality Therapy; Cornea; Eye Diseases; Follow-Up Studies; Glioma; Humans; Infusion Pumps, Implantable; Macaca mulatta; Male; Middle Aged; Radiotherapy | 1990 |
Halogenated pyrimidines as radiosensitizers in the treatment of glioblastoma multiforme.
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Drug Evaluation; Female; Glioblastoma; Humans; Idoxuridine; Infusions, Intravenous; Male; Middle Aged; Prognosis; Radiation-Sensitizing Agents; Radiotherapy Dosage; Subclavian Vein; Time Factors | 1987 |
Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Clinical Trials as Topic; Humans; Infusions, Intra-Arterial; Middle Aged; Mortality; Neoplasm Recurrence, Local; Radiation Injuries; Radiation-Sensitizing Agents; Time Factors; Tomography, X-Ray Computed; Veins | 1988 |
161 other study(ies) available for bromodeoxyuridine and Brain Neoplasms
| Article | Year |
|---|---|
Ellagic Acid Enhances the Antitumor Efficacy of Bevacizumab in an In Vitro Glioblastoma Model.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Apoptosis; Bevacizumab; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; DNA Repair; Drug Resistance, Neoplasm; Drug Synergism; Ellagic Acid; Gene Expression Regulation, Neoplastic; Glioblastoma; Rats | 2019 |
Diazepam inhibits proliferation of human glioblastoma cells through triggering a G0/G1 cell cycle arrest.
Topics: Antimetabolites; Benzimidazoles; Blotting, Western; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coloring Agents; Diazepam; Fluorescent Dyes; G1 Phase; G1 Phase Cell Cycle Checkpoints; GABA Modulators; Glioblastoma; Humans; L-Lactate Dehydrogenase; Resting Phase, Cell Cycle; S Phase; Tetrazolium Salts; Thiazoles | 2013 |
Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells.
Topics: AC133 Antigen; Amphotericin B; Analysis of Variance; Animals; Annexin A5; Antigens, CD; Antineoplastic Agents; Brain Neoplasms; Bromodeoxyuridine; Calcium-Binding Proteins; Cell Cycle; Cell Differentiation; Chemokine CCL2; Coculture Techniques; Culture Media, Conditioned; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Flow Cytometry; Gene Expression Profiling; Glioma; Glycoproteins; Humans; Interleukin-1; Kaplan-Meier Estimate; Macrophages; Magnetic Resonance Imaging; Mice; Microfilament Proteins; Microglia; Neoplasm Transplantation; Nerve Tissue Proteins; Nitric Oxide Synthase Type II; Oligonucleotide Array Sequence Analysis; Peptides; Receptors, CCR2; RNA, Messenger; RNA, Small Interfering; Time Factors; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2014 |
Artemisinin inhibits neuroblastoma proliferation through activation of AHP-activated protein kinase (AMPK) signaling.
Topics: Animals; Antimalarials; Antimetabolites; Antineoplastic Agents; Artemisinins; Blotting, Western; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Humans; Neuroblastoma; Real-Time Polymerase Chain Reaction; RNA; RNA, Small Interfering | 2014 |
Characterization of cancer stem cells and primary cilia in medulloblastoma.
Topics: Animals; Antigens, CD; Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Bromodeoxyuridine; Cilia; Fetus; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Ki-67 Antigen; Magnetic Resonance Imaging; Medulloblastoma; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microtubule-Associated Proteins; Neoplastic Stem Cells; Nestin; Neuropeptides; Receptors, G-Protein-Coupled; Smoothened Receptor; SOXB1 Transcription Factors; Time Factors; Transcription Factors | 2015 |
EphA2 is a key effector of the MEK/ERK/RSK pathway regulating glioblastoma cell proliferation.
Topics: Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Epidermal Growth Factor; Glioblastoma; Humans; MAP Kinase Signaling System; Phosphorylation; Phosphoserine; Receptor, EphA2; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction | 2016 |
Thrombin enhances glioma growth.
Topics: Animals; Anticoagulants; Arginine; Behavior, Animal; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Glioma; Hemostatics; Male; Neoplasm Transplantation; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Tetrazolium Salts; Thiazoles; Thrombin; Time Factors | 2008 |
PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models.
Topics: Analysis of Variance; Animals; Annexin A5; Antineoplastic Agents; bcl-2-Associated X Protein; Brain Neoplasms; Bromodeoxyuridine; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation, Neoplastic; Glioma; Humans; Ligands; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Pioglitazone; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rats; Retinoid X Receptor gamma; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Transfection; Tretinoin; Tumor Stem Cell Assay | 2009 |
Stereological analysis on migration of human neural stem cells in the brain of rats bearing glioma.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Functional Laterality; Glioma; Humans; Neurons; Rats; Rats, Sprague-Dawley; Stem Cells; Stereotaxic Techniques; Time Factors | 2010 |
Decreased pygopus 2 expression suppresses glioblastoma U251 cell growth.
Topics: Adult; Analysis of Variance; beta Catenin; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclin D; Down-Regulation; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Male; Middle Aged; RNA, Small Interfering; Time Factors | 2010 |
Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Adhesion; Cell Cycle; Cell Proliferation; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Models, Animal; RNA, Messenger; SOXB1 Transcription Factors; Spheroids, Cellular; Time Factors; Tumor Cells, Cultured | 2011 |
Activation of PKC-alpha is required for migration of C6 glioma cells.
Topics: Animals; Antimetabolites; Blotting, Western; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Movement; Enzyme Activation; Glioma; Immunohistochemistry; In Situ Nick-End Labeling; Protein Kinase C-alpha; Protein Kinase Inhibitors; Rats | 2010 |
S100B promotes the proliferation, migration and invasion of specific brain metastatic lung adenocarcinoma cell line.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; bcl-X Protein; Blotting, Western; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Lung Neoplasms; Neoplasm Invasiveness; Nerve Growth Factors; RNA, Small Interfering; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Transfection | 2011 |
Lack of angiogenesis in experimental brain metastases.
Topics: Angiopoietin-1; Animals; Brain Neoplasms; Breast Neoplasms; Bromodeoxyuridine; Carcinoma; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Disease Models, Animal; DNA-Binding Proteins; Electron Microscope Tomography; Female; Glial Fibrillary Acidic Protein; Humans; Keratins; Lamins; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Quinolines; Receptor, Platelet-Derived Growth Factor beta; Thiazoles; Vascular Endothelial Growth Factor A | 2011 |
Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest.
Topics: Adolescent; Adult; Aged; Animals; Astrocytoma; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Child; Child, Preschool; Disease Models, Animal; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Glial Fibrillary Acidic Protein; Humans; Male; Mice; Middle Aged; Neoplasm Transplantation; Nuclear Proteins; Nucleolin; Phosphoproteins; RNA-Binding Proteins; RNA, Small Interfering; Xenograft Model Antitumor Assays; Young Adult | 2012 |
Three-dimensional invasion of human glioblastoma cells remains unchanged by X-ray and carbon ion irradiation in vitro.
Topics: Brain Neoplasms; Bromodeoxyuridine; Carbon; Cell Migration Assays; Cell Movement; Cell Proliferation; Collagen Type I; DNA Breaks, Double-Stranded; Glioblastoma; Histones; Humans; Integrin beta1; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Tumor Suppressor p53-Binding Protein 1 | 2012 |
MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L.
Topics: Adult; Aged; Azacitidine; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Cellular Apoptosis Susceptibility Protein; Child; Cohort Studies; Collagen; Decitabine; Down-Regulation; Drug Combinations; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Kaplan-Meier Estimate; Laminin; Male; MicroRNAs; Middle Aged; Oligodendroglioma; Proteoglycans | 2013 |
Anti-proliferative effects of 20-epi-vitamin-D3 analogue, KH1060 in human neuroblastoma: induction of RAR-beta and p21(Cip1).
Topics: Antineoplastic Agents; Blotting, Western; Brain Neoplasms; Bromodeoxyuridine; Calcitriol; Caspase 3; Caspases; Cell Division; Cell Survival; Cholecalciferol; Coloring Agents; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Humans; Inhibitory Concentration 50; Models, Chemical; Neuroblastoma; Proto-Oncogene Proteins c-myc; Receptors, Retinoic Acid; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2003 |
Cancerous stem cells can arise from pediatric brain tumors.
Topics: AC133 Antigen; Animals; Antigens, CD; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Differentiation; Child; Coloring Agents; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Glycoproteins; HMGB Proteins; Humans; Immunohistochemistry; Infant; Neoplasm Transplantation; Nerve Tissue Proteins; Neuroglia; Neurons; Nuclear Proteins; Peptides; Phosphoric Monoester Hydrolases; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; SOXB1 Transcription Factors; Stem Cells; Transcription Factors | 2003 |
Perinecrotic glioma proliferation and metabolic profile within an intracerebral tumor xenograft.
Topics: Animals; Blotting, Western; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Differentiation; Cell Division; Electron Transport Complex IV; Excitatory Amino Acid Transporter 2; Glioma; Glycogen Phosphorylase; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; L-Lactate Dehydrogenase; Male; Microscopy, Confocal; Neoplasm Transplantation; Neovascularization, Pathologic; Rats; Rats, Wistar; Staining and Labeling; Succinic Acid; Time Factors; Transcription Factors; Transplantation, Heterologous; Tumor Cells, Cultured | 2004 |
Treatment of intracranial rat glioma model with implant of radiosensitizer and biomodulator drug combined with external beam radiotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Combined Modality Therapy; Drug Combinations; Drug Implants; Fluorouracil; Glioma; Immunologic Factors; Methotrexate; Phosphonoacetic Acid; Radiation-Sensitizing Agents; Rats | 2004 |
Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth.
Topics: Animals; Antineoplastic Agents; Antitussive Agents; Blood-Brain Barrier; Brain; Brain Neoplasms; Bromodeoxyuridine; Cattle; Cell Count; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Coloring Agents; DNA; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Flow Cytometry; Glioblastoma; Humans; Image Processing, Computer-Assisted; Inhibitory Concentration 50; Mice; Mice, Nude; Mice, SCID; Microcirculation; Microtubules; Mitosis; Models, Biological; Neoplasm Transplantation; Neuroglia; Noscapine; Rats; S Phase; Time Factors; Tubulin | 2004 |
Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
Topics: Administration, Oral; Animals; Apoptosis; bcl-2-Associated X Protein; Brain Neoplasms; Bromodeoxyuridine; Caspase 3; Cell Proliferation; Cell Survival; DNA, Neoplasm; Glioma; Humans; Ki-67 Antigen; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasms, Experimental; Pioglitazone; PPAR gamma; Rats; Rats, Sprague-Dawley; Thiazolidinediones; Treatment Outcome; Tumor Burden | 2006 |
Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chromatin Immunoprecipitation; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Embryo, Mammalian; Flow Cytometry; Glioma; Green Fluorescent Proteins; Luciferases; Mice; Mice, Inbred C57BL; Mice, SCID; Mice, Transgenic; Nerve Tissue Proteins; Neurons; Oligodendrocyte Transcription Factor 2; Stem Cells | 2007 |
Characterization of the subventricular zone neurogenic response to rat malignant brain tumors.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Count; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transplantation; Cerebral Ventricles; Doublecortin Domain Proteins; Doublecortin Protein; Gene Expression Regulation, Neoplastic; Glioma; Intermediate Filament Proteins; Ki-67 Antigen; Luminescent Proteins; Microtubule-Associated Proteins; Nerve Tissue Proteins; Nestin; Neural Cell Adhesion Molecule L1; Neurons; Neuropeptides; Rats; Rats, Inbred F344; Sialic Acids; Time Factors | 2007 |
Abeta treatment and P301L tau expression in an Alzheimer's disease tissue culture model act synergistically to promote aberrant cell cycle re-entry.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antimetabolites; Apoptosis; Blotting, Western; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; DNA Replication; Gene Expression Regulation; Humans; Mitosis; Models, Neurological; Neuroblastoma; tau Proteins; Tissue Culture Techniques | 2007 |
Elevation of osteopontin levels in brain tumor cells reduces burden and promotes survival through the inhibition of cell dispersal.
Topics: Animals; Apoptosis; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; Green Fluorescent Proteins; Humans; In Situ Nick-End Labeling; Osteopontin; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Survival Analysis; Time Factors; Transfection; Transplants | 2008 |
[Radiosensitizers for brain tumors--study of radiotherapy].
Topics: Adolescent; Adult; Antimetabolites; Brain Neoplasms; Bromodeoxyuridine; Child; Culture Techniques; Ependymoma; Female; Glioma; Humans; Infusions, Parenteral; Male; Meningioma; Radiation-Sensitizing Agents | 1967 |
Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR).
Topics: Adult; Brain Neoplasms; Bromodeoxyuridine; Cell Survival; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Drug Evaluation; Female; Glioblastoma; Hematopoietic Stem Cells; Humans; Infusions, Parenteral; Male; Middle Aged; Radiation Tolerance | 1983 |
[Adjuvant immunotherapy with levamisole for malignant glioma].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Bromodeoxyuridine; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Glioblastoma; Humans; Levamisole; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Vincristine | 1983 |
Incorporation and metabolism of exogenous fatty acids by cultured normal and tumoral glial cells.
Topics: Animals; Animals, Newborn; Astrocytes; Brain; Brain Neoplasms; Bromodeoxyuridine; Bucladesine; Carbon Radioisotopes; Cells, Cultured; Cricetinae; Fatty Acids, Nonesterified; Glioma; Kinetics; Neoplasms, Experimental; Neuroglia; Rats | 1983 |
A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation.
Topics: Adult; Brain Neoplasms; Bromodeoxyuridine; Female; Glioblastoma; Humans; Infusions, Parenteral; Male; Melanoma; Middle Aged; Neoplasms; Radiation-Sensitizing Agents; Sarcoma | 1984 |
New therapeutic approaches for brain tumors.
Topics: Brachytherapy; Brain Neoplasms; Bromodeoxyuridine; Eflornithine; Humans; Hyperthermia, Induced; Iodine Radioisotopes; Mitoguazone; Ornithine; Polyamines | 1984 |
Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors.
Topics: Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Drug Evaluation; Female; Glioma; Humans; Injections, Intravenous; Male; Middle Aged; Radiation-Sensitizing Agents | 1984 |
A 32P postlabeling assay for determining the incorporation of bromodeoxyuridine into cellular DNA.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cattle; Cell Line; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; DNA; Phosphorus Radioisotopes; Rats; Thymus Gland | 1984 |
Pharmacological evaluation of intravenous delivery of 5-bromodeoxyuridine to patients with brain tumors.
Topics: Brain Neoplasms; Bromodeoxyuridine; Drug Administration Schedule; Glioma; Humans; Infusions, Parenteral; Kinetics | 1984 |
Proliferating cell nuclear antigen expression in rat glioma model: comparison with bromodeoxyuridine labeling index.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Female; Glioma; Nuclear Proteins; Pregnancy; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar | 1994 |
Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
Topics: Adult; Affinity Labels; Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Epitopes; Female; Glioblastoma; Glioma; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Proteins; Nuclear Proteins; Paraffin Embedding; Regression Analysis; S Phase | 1994 |
Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents.
Topics: Acyclovir; Animals; Antiviral Agents; Brain Neoplasms; Bromodeoxyuridine; Gliosarcoma; Male; Radiation-Sensitizing Agents; Rats; Rats, Inbred F344; Simplexvirus; Thymidine Kinase; Transfection; Tumor Cells, Cultured | 1995 |
alpha-Difluoromethylornithine increases the anti-tumor effect of cis-diamminedichloroplatinum in G-XII rat glioma.
Topics: Acetyltransferases; Animals; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Movement; Cells, Cultured; Cisplatin; Culture Techniques; Drug Synergism; Drug Therapy, Combination; Eflornithine; Glioma; Ornithine Decarboxylase; Rats | 1995 |
Proliferative potential and prognostic evaluation of low-grade astrocytomas.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; Disease Progression; Female; Humans; Infant; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Survival Analysis; Tumor Cells, Cultured | 1994 |
Enhancement of ACNU cytotoxicity by pretreatment with O6-methylguanine in ACNU-resistant brain tumors.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Densitometry; Drug Resistance; Drug Synergism; Guanine; Humans; Male; Neoplasm Transplantation; Nimustine; Rats; Rats, Wistar; Tetrazolium Salts; Thiazoles; Transplantation, Heterologous; Tumor Cells, Cultured | 1994 |
Changes of the bromodeoxyuridine labeling index of astrocytic tumors between primary and recurrent lesions.
Topics: Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Recurrence, Local | 1994 |
The prognostic implications of histologic classification and bromodeoxyuridine labeling index of mixed gliomas.
Topics: Adolescent; Adult; Astrocytes; Brain Neoplasms; Bromodeoxyuridine; Child; Child, Preschool; Female; Glioma; Humans; Immunohistochemistry; Infant; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglia; Prognosis; Survival Analysis | 1994 |
Prognostic significance of bromodeoxyuridine labeling in primary and recurrent glioblastoma multiforme.
Topics: Adult; Aged; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Glioblastoma; Humans; Infusions, Intravenous; Male; Middle Aged; Mitotic Index; Neoplasm Recurrence, Local; Prognosis; Radiotherapy, Adjuvant; Reoperation; Survival Rate | 1994 |
Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme.
Topics: Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Female; Glioblastoma; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Proteins; Nuclear Proteins; Nucleolus Organizer Region | 1994 |
Clinical evaluation of DNA index in human brain tumors.
Topics: Adult; Aged; Aneuploidy; Brain Neoplasms; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Flow Cytometry; Humans; Middle Aged; Prognosis | 1993 |
Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells.
Topics: Animals; Astrocytes; Axons; Brain Neoplasms; Bromodeoxyuridine; Cell Transplantation; Glioma; Immunohistochemistry; Male; Microinjections; Microscopy, Electron; Myelin Sheath; Neoplasm Invasiveness; Neoplasm Transplantation; Phenotype; Rats; Rats, Wistar; Tumor Cells, Cultured | 1993 |
A comparison of AgNOR staining and BUDR labeling of metastatic tumors of the brain.
Topics: Brain Neoplasms; Bromodeoxyuridine; Humans; Methods; Nucleolus Organizer Region | 1993 |
Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling.
Topics: Age Factors; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Glioblastoma; Humans; Male; Prognosis; Survival Analysis | 1993 |
Immunohistochemical double staining with immunogold-silver and alkaline phosphatase to identify nuclear markers of cellular proliferation.
Topics: Alkaline Phosphatase; Biomarkers; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Nucleus; Glioblastoma; Humans; Idoxuridine; Immunohistochemistry | 1993 |
Morphological appearance, growth kinetics and glial fibrillary acidic protein (GFAP) expression in primary in vitro explant culture of astrocytic neoplasms.
Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; Female; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Immunoenzyme Techniques; Male; Tumor Cells, Cultured | 1993 |
The correlation of two argyrophilic nucleolar organizer region counting methods with bromodeoxyuridine-labeling index: a study of metastatic tumors of the brain.
Topics: Adult; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Female; Humans; Immunohistochemistry; Male; Middle Aged; Nucleolus Organizer Region; Ploidies; S Phase; Silver Staining | 1993 |
A new method for analyzing the cell kinetics of human brain tumors by double labeling with bromodeoxyuridine in situ and with iododeoxyuridine in vitro.
Topics: Biopsy; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Humans; Idoxuridine; Immunohistochemistry; In Vitro Techniques; Regression Analysis; S Phase | 1993 |
Proliferation markers in gliomas: a comparison of BUDR, KI-67, and MIB-1.
Topics: Biomarkers, Tumor; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Coloring Agents; Glioma; Humans; Ki-67 Antigen; Linear Models; Neoplasm Proteins; Nuclear Proteins; Prospective Studies; Reproducibility of Results; Retrospective Studies | 1995 |
Effect of hyperthermia on cyclin B expression in a human glioblastoma cell line.
Topics: Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; CDC2 Protein Kinase; Cell Cycle; Cyclins; DNA, Neoplasm; Flow Cytometry; Glioma; Humans; Hyperthermia, Induced; Immunohistochemistry; Protein Binding; Tumor Cells, Cultured | 1995 |
The sequential changes in DNA synthesis, glucose utilization, protein synthesis, and peripheral benzodiazepine receptor density in C6 brain tumors after chemotherapy to predict the response of tumors to chemotherapy.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Bromodeoxyuridine; Carmustine; DNA; Female; Glioma; Glucose; Immunohistochemistry; Monitoring, Physiologic; Protein Biosynthesis; Rats; Rats, Wistar; Receptors, GABA-A | 1996 |
Proliferative activity of central neurocytoma: measurement of tumor volume doubling time, MIB-1 staining index and bromodeoxyuridine labeling index.
Topics: Adult; Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Female; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Neurocytoma; Staining and Labeling; Tomography, X-Ray Computed | 1997 |
A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antigens, Nuclear; Biomarkers, Tumor; Brain Neoplasms; Bromodeoxyuridine; Cell Survival; Female; Glioma; Humans; Ki-67 Antigen; Life Tables; Male; Middle Aged; Multivariate Analysis; Nuclear Proteins; Prognosis; Proliferating Cell Nuclear Antigen; Proportional Hazards Models; Prospective Studies | 1997 |
S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
Topics: Aneuploidy; Antimetabolites; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Diploidy; DNA, Neoplasm; Flow Cytometry; Glioma; Humans; Meningioma; Oligodendroglioma; Ploidies; S Phase | 1997 |
Enzyme-based antigen localization and quantitation in cell and tissue samples (Midwestern assay).
Topics: Alzheimer Disease; Animals; Antibodies, Antinuclear; Brain Neoplasms; Bromodeoxyuridine; Cytoskeletal Proteins; DNA; Enzyme-Linked Immunosorbent Assay; Glial Fibrillary Acidic Protein; Humans; Ki-67 Antigen; Mice; Spinal Cord; Substance P; tau Proteins; Tumor Cells, Cultured | 1997 |
Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma mult
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Analysis of Variance; Antimetabolites, Antineoplastic; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Female; Glioblastoma; Glioma; Humans; Karnofsky Performance Status; Male; Middle Aged; Proportional Hazards Models; Radiation-Sensitizing Agents; Regression Analysis; Retrospective Studies | 1998 |
Estimation of volume doubling time and cell loss in an experimental rat glioma model in vivo.
Topics: Animals; Apoptosis; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Glioma; Immunohistochemistry; In Situ Nick-End Labeling; Kinetics; Magnetic Resonance Imaging; Rats; Rats, Wistar; Time Factors | 1998 |
Final report on the University of California-San Francisco experience with bromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Brain Neoplasms; Bromodeoxyuridine; Clinical Trials as Topic; Follow-Up Studies; Glioma; Humans; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Proportional Hazards Models; San Francisco; Time Factors | 1999 |
A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Diagnosis, Computer-Assisted; Female; Glioma; Humans; Male; Neoplasm Staging; Prognosis; World Health Organization | 1999 |
Prognostic relevance of MIB-1 immunoreactivity, S-phase fraction, 5-bromo-2'-deoxyuridine labeling indices, and mitotic figures in gliomas.
Topics: Adult; Aged; Antigens, Nuclear; Brain Neoplasms; Bromodeoxyuridine; Disease-Free Survival; DNA, Neoplasm; Female; Flow Cytometry; Glioma; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Male; Middle Aged; Mitosis; Mitotic Index; Nuclear Proteins; Prognosis; Retrospective Studies; S Phase | 1999 |
BUdR radiosensitization in anaplastic astrocytoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Humans; Lomustine; Procarbazine; Radiation-Sensitizing Agents; Vincristine | 1999 |
Optimizing radiation therapy of brain tumours by combination of 5-bromo-2-deoxy-uridine & 2-deoxy-D-glucose.
Topics: Brain Neoplasms; Bromodeoxyuridine; Deoxyglucose; DNA Damage; Humans; Micronucleus Tests; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy; Tumor Cells, Cultured | 1999 |
Analysis of 76Br-BrdU in DNA of brain tumors after a PET study does not support its use as a proliferation marker.
Topics: Aged; Astrocytoma; Brain Neoplasms; Bromine Radioisotopes; Bromodeoxyuridine; DNA, Neoplasm; Female; Humans; Magnetic Resonance Imaging; Male; Meningioma; Middle Aged; Radiation-Sensitizing Agents; Tomography, Emission-Computed | 2001 |
Prognostic significance of DNA ploidy and proliferation rate in human astrocytic gliomas.
Topics: Adult; Aneuploidy; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Humans; Male; Middle Aged; Multivariate Analysis; Nucleolus Organizer Region; Ploidies; Prognosis; S Phase; Silver Staining; Survival Rate | 2000 |
Co-transduction of Apaf-1 and caspase-9 highly enhances p53-mediated apoptosis in gliomas.
Topics: Adenoviridae; Apoptosis; Apoptotic Protease-Activating Factor 1; Brain Neoplasms; Bromodeoxyuridine; Caspase 9; Caspases; Cell Survival; fas Receptor; Flow Cytometry; Gene Expression; Glioma; Humans; Immunoblotting; Neuropeptides; Proteins; Receptors, Tumor Necrosis Factor; Transduction, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
Hydroxyl free radicals induce cell differentiation in SK-N-MC neuroblastoma cells.
Topics: Acetylcholinesterase; Adolescent; Brain Neoplasms; Bromodeoxyuridine; Cell Differentiation; Cell Division; Cell Survival; DNA, Neoplasm; Humans; Hydrogen Peroxide; Hydroxyl Radical; Iron; Neoplasm Proteins; Neuraminidase; Neuroblastoma; Tumor Cells, Cultured | 2002 |
[Chemo-radiotherapy of brain tumors (author's transl)].
Topics: Brain Neoplasms; Bromodeoxyuridine; Glioma; Humans | 1976 |
Post-operative stereotactic Curie-therapy using the iridium-192 GammaMed contact irradiation apparatus combined with radio-sensitizers in treating multiform glioblastomas.
Topics: Brain Neoplasms; Bromodeoxycytidine; Bromodeoxyuridine; Deoxycytidine; Glioblastoma; Humans; Iridium; Postoperative Period; Radiation-Sensitizing Agents; Radioisotopes; Radiotherapy; Radiotherapy Dosage; Stereotaxic Techniques | 1978 |
Proliferative potential and outcome in pediatric astrocytic tumors.
Topics: Adolescent; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; Combined Modality Therapy; Female; Glioblastoma; Glioma; Humans; Infant; Male; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome | 1992 |
Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
Topics: Antigens, Neoplasm; Astrocytoma; Biomarkers, Tumor; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Cerebellar Neoplasms; Craniotomy; Glioblastoma; Humans; Immunoenzyme Techniques; Infusions, Intravenous; Medulloblastoma; Meningeal Neoplasms; Meningioma; Neoplasm Recurrence, Local; Neurilemmoma; Nuclear Proteins; Proliferating Cell Nuclear Antigen | 1992 |
Comparison of brain tumor growth kinetics by proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) labeling.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; Female; Humans; Infant; Male; Middle Aged; Nuclear Proteins; Proliferating Cell Nuclear Antigen | 1992 |
Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index.
Topics: Adolescent; Adult; Aged; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; Ependymoma; Female; Follow-Up Studies; Humans; Infant; Male; Middle Aged; Neoplasm Recurrence, Local; Spinal Cord; Spinal Cord Neoplasms | 1992 |
Proliferative characteristics of juvenile pilocytic astrocytomas determined by bromodeoxyuridine labeling.
Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Child; Child, Preschool; Female; Humans; Immunohistochemistry; Infant; Male; Neoplasm Recurrence, Local | 1992 |
Modulation of BUdR labeling index in rat brain tumors following intracarotid ACNU administration.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Carotid Arteries; Cell Division; Dose-Response Relationship, Drug; Glioma; Injections, Intra-Arterial; Neoplasm Transplantation; Nimustine; Rats; Time Factors; Tumor Cells, Cultured | 1992 |
[Proliferation kinetics of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine].
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Child; Child, Preschool; Female; Glioma; Humans; Idoxuridine; Male; Meningeal Neoplasms; Meningioma; Middle Aged; S Phase | 1992 |
Bromodeoxyuridine hypersensitivity of metastatic melanoma cells.
Topics: Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Oxygen | 1992 |
A comparison of CT contrast enhancement and BUDR labeling indices in moderately and highly anaplastic astrocytomas of the cerebral hemispheres.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child; Child, Preschool; Female; Humans; Infant; Male; Middle Aged; Sex Factors; Tomography, X-Ray Computed | 1992 |
Histological grading and bromodeoxyuridine labeling index of astrocytomas. Comparative study in a series of 60 cases.
Topics: Adolescent; Adult; Age Factors; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child; Child, Preschool; Female; Glioblastoma; Humans; Infant; Male; Middle Aged; Regression Analysis; S Phase | 1991 |
Halogenated pyrimidines as radiosensitizers for high grade glioma: revisited.
Topics: Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Glioblastoma; Humans; Radiation-Sensitizing Agents | 1991 |
Correlation of in vitro bromodeoxyuridine labeling index and DNA aneuploidy with survival or recurrence in brain-tumor patients.
Topics: Adolescent; Adult; Aged; Aneuploidy; Brain Neoplasms; Bromodeoxyuridine; Child; Child, Preschool; DNA, Neoplasm; Female; Flow Cytometry; Humans; Infant; Male; Middle Aged; Neoplasm Recurrence, Local; Staining and Labeling; Survival Rate | 1990 |
Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Capillary Permeability; Cell Division; Copper; Diet; Fibronectins; Glioma; Lung Neoplasms; Neovascularization, Pathologic; Penicillamine; Rabbits; Rats | 1990 |
Cell kinetic analysis of human brain tumors by in situ double labelling with bromodeoxyuridine and iododeoxyuridine.
Topics: Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Glioma; Humans; Idoxuridine; Meningioma | 1992 |
[Evaluation of 201Tl SPECT in patients with glioma: a comparative study with histological diagnosis, clinical feature and proliferative activity].
Topics: Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Female; Glioma; Humans; Male; Middle Aged; Predictive Value of Tests; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1991 |
Rapid detection of gene expression.
Topics: Adenoma; Base Sequence; Brain; Brain Neoplasms; Bromodeoxyuridine; DNA Probes; Gene Expression; Humans; Immunoblotting; Insulin-Like Growth Factor II; Meningioma; Molecular Sequence Data; Nucleic Acid Hybridization; Pituitary Neoplasms; RNA, Messenger; Sensitivity and Specificity | 1991 |
A three-dimensional micro-organ culture system optimized for in vitro growth of human malignant brain tumors.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Carmustine; Cell Survival; Glioma; Humans; Immunohistochemistry; Macrophages; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured | 1991 |
Immunohistochemical demonstration of DNA polymerase alpha in human brain-tumor cells.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Antigens, Surface; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Division; DNA Polymerase II; Humans; Immunohistochemistry; Ki-67 Antigen; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Tumor Cells, Cultured | 1990 |
Metastatic intracranial carcinoid with immunohistochemical observation. Case report.
Topics: Aged; Brain Neoplasms; Bromodeoxyuridine; Carcinoid Tumor; Colonic Neoplasms; Humans; Immunohistochemistry; Male; Occipital Lobe; Serotonin; Somatostatin | 1990 |
[New development in clinicopathological diagnosis of brain tumors].
Topics: Brain Neoplasms; Bromodeoxyuridine; Cell Division; Glioma; Humans; Neoplasm Invasiveness | 1991 |
Correlation between bromodeoxyuridine-labeling indices and patient prognosis in cerebral astrocytic tumors of adults.
Topics: Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Follow-Up Studies; Glioma; Humans; Neoplasm Recurrence, Local; Prognosis; Survival Rate | 1991 |
Simultaneous immunohistochemical detection of IUdR and BrdU infused intravenously to cancer patients.
Topics: Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Colonic Neoplasms; Humans; Idoxuridine; Immunohistochemistry; Infusions, Intravenous; Leukemia; Lymphoma; Pilot Projects; S Phase; Time Factors | 1991 |
Observations regarding DNA replication sites in human cells in vivo following infusions of iododeoxyuridine and bromodeoxyuridine.
Topics: Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Nucleus; DNA Replication; Gastrointestinal Neoplasms; Humans; Idoxuridine; Immunoenzyme Techniques; Leukemia; Leukemia, Myeloid; Neoplasms; S Phase | 1991 |
Determination of proliferative activities in human brain tumor specimens: a comparison of three methods.
Topics: Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Humans; Hyperbaric Oxygenation; Immunohistochemistry; Ki-67 Antigen; Mitotic Index; Nuclear Proteins | 1991 |
Relationship of invasiveness to proliferating activity and to cytoskeletal protein production in human neuroepithelial tumors maintained in an organ culture system: use of human cortex and dura as supporting matrices.
Topics: Brain Neoplasms; Bromodeoxyuridine; Cell Division; Cell Line; Cerebral Cortex; Dura Mater; Glial Fibrillary Acidic Protein; Glioma; Humans; Intermediate Filament Proteins; Medulloblastoma; Neoplasm Invasiveness; Neurofilament Proteins; Organ Culture Techniques | 1990 |
Immunocytochemical evaluation of proliferative activity in human brain tumours.
Topics: Antibodies, Monoclonal; Antigens, Surface; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Humans; Immunohistochemistry; Ki-67 Antigen; Nuclear Proteins | 1990 |
Differential drug sensitivity conferred by growth status detected in a mixed population of cycling and noncycling cells.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Carmustine; Cell Cycle; DNA Damage; DNA, Neoplasm; Rats; Sister Chromatid Exchange; Time Factors; Tumor Cells, Cultured | 1990 |
Rapid estimation of the proliferating index of brain tumours.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Cell Count; Cell Division; Female; Glioma; Humans; Immunohistochemistry; Male; Meningioma; Middle Aged | 1990 |
Cell kinetics of rat 9L brain tumors determined by double labeling with iodo- and bromodeoxyuridine.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Glioma; Idoxuridine; Rats; Tumor Cells, Cultured | 1990 |
Cell-kinetic characteristics of human brain tumors.
Topics: Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Glioma; Humans; Kinetics; Male; Meningeal Neoplasms; Meningioma; Middle Aged | 1990 |
[Application of flow cytometry to the chemosensitivity test by the BrdU labeling method; a preliminary report].
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Brain Neoplasms; Bromodeoxyuridine; Flow Cytometry; Humans; Nimustine; Nitrosourea Compounds; Staining and Labeling | 1987 |
[Growth fraction of human central nervous system tumors measured by using bromodeoxyuridine].
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Child; Female; Glioma; Humans; Male; Middle Aged | 1987 |
[Immunohistochemical study of S-phase cells in human gliomas].
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child; Female; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Immunohistochemistry; Interphase; Male; Middle Aged; Staining and Labeling; Vimentin | 1988 |
Cell kinetics of intracerebrally implanted RG-C6 tumors in rats--effects of intracarotid hyperosmolar mannitol measured by 3H-thymidine autoradiography and bromodeoxyuridine uptake.
Topics: Animals; Autoradiography; Brain Neoplasms; Bromodeoxyuridine; Carotid Artery, Internal; Cell Cycle; Glioma; Hypertonic Solutions; Infusions, Intra-Arterial; Male; Mannitol; Neoplasm Transplantation; Rats; Rats, Inbred Strains; Thymidine; Tritium | 1988 |
Rapid in situ cellular kinetics of intracerebral tumor angiogenesis using a monoclonal antibody to bromodeoxyuridine.
Topics: Animals; Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Endothelium, Vascular; Immunohistochemistry; Male; Neovascularization, Pathologic; Rabbits | 1989 |
[Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Bromodeoxyuridine; Carotid Artery, Internal; Cell Division; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Glioma; Infusions, Intra-Arterial; Infusions, Parenteral; Male; Mannitol; Neoplasm Transplantation; Nimustine; Rats; Rats, Inbred F344 | 1989 |
Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors.
Topics: Aneuploidy; Antibodies, Monoclonal; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; DNA; Flow Cytometry; Glioblastoma; Humans; Immunoenzyme Techniques; Meningeal Neoplasms; Meningioma | 1989 |
Prognostic implications of the bromodeoxyuridine labeling index of human gliomas.
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Glioblastoma; Humans; Neoplasm Recurrence, Local; Prognosis; Time Factors | 1989 |
Variability in the proliferative potential of human gliomas.
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Glioblastoma; Glioma; Humans; Interphase | 1989 |
Mucocutaneous complications of intraarterial 5-bromodeoxyuridine and radiation.
Topics: Alopecia; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Conjunctivitis, Bacterial; Facial Dermatoses; Humans; Infusions, Intra-Arterial; Mouth Diseases; Nail Diseases; Radiation Dosage; Radiation-Sensitizing Agents; Radiodermatitis; Radiography; Ulcer | 1989 |
[Histopathologic changes and tumor cell kinetics after hyperthermia and/or radiation therapy in a rat glioma model: bromodeoxyuridine (BUdR) labelling index].
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Combined Modality Therapy; Glioma; Hyperthermia, Induced; Neoplasm Transplantation; Rats; Rats, Inbred Strains | 1989 |
[A trial of ACNU and radiation therapy with sensitizing agents for malignant gliomas].
Topics: Acyclovir; Adolescent; Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Evaluation Studies as Topic; Female; Glioma; Humans; Male; Middle Aged; Nimustine; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy Dosage; Remission Induction; Vidarabine | 1989 |
The proliferative activity of neurilemomas.
Topics: Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Child; Cranial Nerve Neoplasms; Female; Humans; Immunoenzyme Techniques; Interphase; Male; Middle Aged; Neurilemmoma; Neuroma, Acoustic; Spinal Cord Neoplasms | 1989 |
Correlation of histopathological features and proliferative potential of gliomas.
Topics: Adult; Brain Neoplasms; Bromodeoxyuridine; Female; Glioma; Humans; Immunohistochemistry; Male; Necrosis | 1989 |
In vitro BUdR labeling of brain-tumor specimens.
Topics: Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Humans | 1989 |
The effect of bromodeoxyuridine and ultraviolet light on 9L rat brain tumor cells.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Line; Cell Survival; DNA Repair; DNA, Neoplasm; DNA, Single-Stranded; In Vitro Techniques; Photochemotherapy; Rats; Ultraviolet Rays | 1989 |
Cell kinetics in leukaemia and solid tumours studied with in vivo bromodeoxyuridine and flow cytometry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Female; Flow Cytometry; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Stomach Neoplasms | 1989 |
[Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
Topics: Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; DNA, Neoplasm; Flow Cytometry; Humans; Immunohistochemistry; Interphase; Predictive Value of Tests | 1989 |
[Factors affecting the prognosis of brain tumors].
Topics: Age Factors; Antibodies, Monoclonal; Astrocytoma; Biomarkers, Tumor; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Epidermal Growth Factor; ErbB Receptors; Glioblastoma; Humans; Meningioma; Oligodendroglioma; Oncogenes; Prognosis | 1988 |
Proliferative characteristics of intracranial and spinal tumors of developmental origin.
Topics: Adolescent; Adult; Brain Neoplasms; Bromodeoxyuridine; Child; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Mitotic Index; Neoplasms, Germ Cell and Embryonal; Spinal Neoplasms | 1988 |
In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
Topics: Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Humans; Immunohistochemistry; Interphase | 1989 |
Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues.
Topics: Aged; Antibodies, Monoclonal; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child, Preschool; Female; Glioblastoma; Glioma; Histocytochemistry; Humans; Immunochemistry; Interphase; Male; Meningioma; Middle Aged | 1985 |
Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine.
Topics: Antibodies, Monoclonal; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Glioblastoma; Humans; Immunoenzyme Techniques; Interphase; Meningioma; Metabolic Clearance Rate | 1985 |
Distinctive eruption characterized by linear supravenous papules and erythroderma following broxuridine (bromodeoxyuridine) therapy and radiotherapy.
Topics: Brain Neoplasms; Bromodeoxyuridine; Dermatitis, Exfoliative; Drug Eruptions; Glioblastoma; Humans; Male; Middle Aged; Radiation-Sensitizing Agents; Skin | 1986 |
Pediatric central nervous system tumors: a cell kinetic study with bromodeoxyuridine.
Topics: Adolescent; Astrocytoma; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Cerebellar Neoplasms; Child; Child, Preschool; DNA, Neoplasm; Female; Glioblastoma; Humans; Immunoenzyme Techniques; Infant; Male; Medulloblastoma; Prognosis | 1986 |
Proliferative potential of vascular components in human glioblastoma multiforme.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Vessels; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Cell Transformation, Neoplastic; Child; Endothelium; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local | 1987 |
Cell kinetics of human brain tumors: in vivo study with bromodeoxyuridine and flow cytometry.
Topics: Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; DNA, Neoplasm; Female; Flow Cytometry; Humans; Male; Meningioma; Middle Aged; Mitosis; Time Factors | 1988 |
Prognostic implications of the proliferative potential of low-grade astrocytomas.
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Humans; Interphase; Neoplasm Recurrence, Local; Prognosis | 1988 |
[Effect of ACNU against experimental brain tumor--immunohistochemical study using anti-BrdU monoclonal antibody].
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Brain Neoplasms; Bromodeoxyuridine; Carcinoma 256, Walker; Cell Cycle; Female; Immunohistochemistry; Injections, Intravenous; Injections, Spinal; Nimustine; Rats | 1988 |
Intra-arterial 5-bromo-2-deoxyuridine (BUdR) radiosensitization with external beam radiation in rhesus monkeys: toxicity study.
Topics: Animals; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Infusions, Intra-Arterial; Macaca mulatta; Magnetic Resonance Imaging; Radiation-Sensitizing Agents | 1988 |
Comparison of bromodeoxyuridine labeling indices obtained from tissue sections and flow cytometry of brain tumors.
Topics: Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Flow Cytometry; Humans; Immunoenzyme Techniques | 1988 |
Effects of fixation time and enzymatic digestion on immunohistochemical demonstration of bromodeoxyuridine in formalin-fixed, paraffin-embedded tissue.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Digestive System; Formaldehyde; Humans; Immunohistochemistry; Male; Paraffin; Peptide Hydrolases; Rats; Rats, Inbred Strains | 1988 |
The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling.
Topics: Adult; Aged; Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Ependymoma; Female; Humans; Immunoenzyme Techniques; Infant; Male; Middle Aged; Mitotic Index; Prognosis; Spinal Cord Neoplasms | 1988 |
Sequence of centromere separation: differential replication of pericentric heterochromatin in multicentric chromosomes.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Line; Centromere; Chromosomes; DNA Replication; Heterochromatin; Karyotyping; Kinetics; L Cells; Mice | 1988 |
Proliferative potential of brain metastases.
Topics: Adenocarcinoma; Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Carcinoma; Cell Division; Female; Humans; Interphase; Male; Middle Aged; Mitotic Index | 1988 |
Cell kinetics studies of human brain tumors by in vitro labeling using anti-BUdR monoclonal antibody.
Topics: Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; DNA, Neoplasm; Female; Humans; In Vitro Techniques; Interphase; Kinetics; Male | 1988 |
Bromodeoxyuridine: a comparison of its photosensitizing and radiosensitizing properties.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Line; Cell Survival; In Vitro Techniques; Radiation-Sensitizing Agents; Rats; Ultraviolet Rays | 1988 |
Potentiation of anticoagulant effect of coumadin by 5-bromo-2'-deoxyuridine (BUDR)
Topics: Brain Neoplasms; Bromodeoxyuridine; Drug Synergism; Humans; Male; Middle Aged; Prothrombin Time; Warfarin | 1988 |
Flow cytometric determination of modal DNA population in relation to proliferative potential of human intracranial neoplasms.
Topics: Brain Neoplasms; Bromodeoxyuridine; DNA; Flow Cytometry; Humans; Immunohistochemistry; Neoplasm Invasiveness; Tissue Distribution | 1988 |
S-phase fraction of human brain tumors in situ measured by uptake of bromodeoxyuridine.
Topics: Adult; Brain Neoplasms; Bromodeoxyuridine; Child; Female; Humans; Immunoenzyme Techniques; Injections, Intravenous; Interphase; Male; Middle Aged | 1986 |
Growth activity of tumors at different intracranial structures: immunohistochemical study with bromodeoxyuridine.
Topics: Animals; Astrocytes; Brain Neoplasms; Bromodeoxyuridine; Carcinoma 256, Walker; Cerebral Cortex; Cerebral Ventricle Neoplasms; Choroid Plexus; Female; Meningeal Neoplasms; Mitosis; Neoplasm Transplantation; Rats; Rats, Inbred Strains | 1986 |
[Effect of CDDP on cultured glioma cell lines: analysis of cell kinetics by flow cytometry].
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Line; Cells, Cultured; Cisplatin; Flow Cytometry; Glioma; Rats | 1986 |
[A cell kinetic study of human central nervous system tumors with 5-bromodeoxyuridine (BrdU)].
Topics: Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cells, Cultured; DNA, Neoplasm; Humans; Immunoenzyme Techniques; Mitotic Index; Spinal Cord Neoplasms | 1985 |
In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; DNA; Ependymoma; Female; Glioma; Humans; Infant; Kinetics; Male; Medulloblastoma; Middle Aged | 1986 |
Rapid detection of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in 9L brain tumor cells in vitro and in situ.
Topics: Animals; Antibodies, Monoclonal; Brain; Brain Neoplasms; Bromodeoxyuridine; Cells, Cultured; DNA, Neoplasm; Flow Cytometry; Interphase; Kinetics; Microscopy, Fluorescence; Neoplasm Transplantation; Rats; Rats, Inbred F344 | 1985 |
[The use of radiosensitizing agents in radiotherapy].
Topics: Brain Neoplasms; Bromodeoxyuridine; Dactinomycin; DNA; Fluorouracil; Glycogen; Humans; Neoplasms; Oxygen; Radiation-Sensitizing Agents; RNA; Vitamin K | 1972 |
Experimental and clinical studies of radiosensitizers in brain tumors, with special reference to BUdR-antimetabolite continuous regional infusion-radiation therapy (BAR therapy).
Topics: Adult; Antimetabolites; Brain Neoplasms; Bromodeoxyuridine; Culture Techniques; Humans; Injections, Intra-Arterial; Male; Radiation-Sensitizing Agents | 1965 |
Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Culture Techniques; DNA; Floxuridine; Fluorouracil; Follow-Up Studies; Glioma; Humans; Meningioma; Methotrexate; Oligodendroglioma; Radiation-Sensitizing Agents; Thymidine | 1968 |
[Treatment of malignant brain tumors by BAR therapy].
Topics: Adolescent; Adult; Arteries; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child; Ependymoma; Female; Follow-Up Studies; Glioblastoma; Humans; Infusions, Parenteral; Male; Melanoma; Meningioma; Middle Aged; Neoplasm Metastasis; Oligodendroglioma; Papilloma | 1968 |
Current trends in the chemotherapy of brain tumors with special reference to glioblastomas.
Topics: Alkaloids; Antibiotics, Antineoplastic; Antineoplastic Agents; Azaguanine; Blood Vessel Prosthesis; Blood-Brain Barrier; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Cell Transformation, Neoplastic; Disease Models, Animal; Fluorouracil; Glioblastoma; Humans; Injections, Intra-Arterial; Injections, Spinal; Mechlorethamine; Methotrexate; Nitroso Compounds; Thiotepa; Time Factors; Urea; Vincristine | 1969 |
[Results of postoperative treatment of glioblastoma multiforme with a radiation-sensitizing substance (5-bromo-2-deoxyuridine)].
Topics: Adult; Aged; Alopecia; Brain Edema; Brain Neoplasms; Bromodeoxyuridine; Drug Interactions; Exanthema; Glioblastoma; Glossitis; Humans; Leukopenia; Methotrexate; Middle Aged; Postoperative Care; Prognosis; Radiation-Sensitizing Agents; Stomatitis; Thrombocytopenia | 1971 |
[Treatment of malignant brain tumors by the intrathecal administration of BAR (EUdR-antimetabolite-radiation)].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antimetabolites; Brain Neoplasms; Bromodeoxyuridine; Carcinoma, Squamous Cell; Child; Child, Preschool; Ependymoma; Female; Glioblastoma; Humans; Injections, Spinal; Male; Medulloblastoma; Meningioma; Methotrexate; Middle Aged; Mitomycins; Pinealoma; Radiation-Sensitizing Agents; Radiotherapy, High-Energy; Retinoblastoma | 1972 |
[Clinical and experimental results of interstitial Curie-therapy combined with radiosensitizing agents in DS carcinoma of the rat and in infiltrating brain neoplasms].
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Carcinosarcoma; Cytidine; Ependymoma; Glioblastoma; Humans; Iridium; Methotrexate; Oligodendroglioma; Radiation-Sensitizing Agents; Rats; Thymidine | 1972 |
[Clinical and experimental results of interstitial Brachy-Curie-therapy combined with radiation sensitizing agents in infiltrative growing brain neoplasms].
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Carcinosarcoma; Cytidine; Fluorouracil; Guanosine; Iridium; Methotrexate; Neoplasms, Experimental; Radiation-Sensitizing Agents; Rats; Thymine | 1972 |
[Chemotherapy of metastatic brain tumors, with special reference to continuous intracranial infusion of mitomycin C and a radiosensitizer, BUdR].
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Bromodeoxyuridine; Female; Humans; Injections, Spinal; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Metastasis; Radiation-Sensitizing Agents | 1971 |
[Effect of BAR therapy in a case of malignant glioma with extracranial metastasis].
Topics: Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; DNA, Neoplasm; Head and Neck Neoplasms; Humans; Male; Neoplasm Metastasis; Radiation-Sensitizing Agents | 1970 |
[Radiotherapy of brain tumors].
Topics: Adult; Boron Compounds; Brain Neoplasms; Bromodeoxyuridine; Female; Humans; Radiation-Sensitizing Agents | 1969 |